The New Paper

March 25, 2021

AstraZeneca releases updated coronavirus vaccine data

AstraZeneca published revised efficacy data for its coronavirus vaccine, now finding that its vaccine is 76% effective in preventing symptomatic cases (down from 79%) while remaining 100% effective against severe cases and hospitalizations. The revision follows a statement issued by US health officials this week, which suggested that AstraZeneca may have used outdated or incomplete data in its initial findings.
This story is from the March 25, 2021 edition of The New Paper – a clear, concise daily briefing that makes fact-first news easy to consume. Try it today.